The Latest in AML

MD Anderson–led alliance seeks to advance leukemia drug development

January 9, 2019

Tests can identify leukemia risk in newborns with Down syndrome

January 4, 2019

Higher AML, MDS risk linked to solid tumor chemotherapy

January 3, 2019

Quizartinib improves survival of FLT3-mutated AML

January 2, 2019

AML

NCI director: Data failures cost lives

December 12, 2018

In IDH-mutated AML, first-line IDH inhibitors plus chemo may boost remission

December 5, 2018

AML

FLT3 inhibitor moves forward in newly diagnosed AML

December 4, 2018

AML

Model bests IPSS-R for predicting survival, risk for AML in myelodysplastic syndrome

December 3, 2018

Beat AML trial delivers genomic results in 7 days

December 2, 2018

AML

FDA warns of serious side effect of AML treatment

November 30, 2018

AML

Your guide to ASH 2018: Abstracts to watch

November 29, 2018

FDA approves gilteritinib for AML with FLT3 mutation

November 28, 2018

AML

FDA approves glasdegib for AML

November 21, 2018

AML

Venetoclax gets accelerated approval in older AML patients

November 21, 2018

AML

Azacitidine-nivolumab combo 'encouraging' in AML

November 14, 2018

AML